Key Points
- Boeing has secured two major next-generation fighter programs, winning the Air Force’s F-47 program and the Navy’s F/A-XX contract after competing against Lockheed Martin and Northrop Grumman.
- The victories could provide Boeing with decades of future defense work, with each development program valued at more than $20 billion and lifetime production potentially reaching hundreds of billions of dollars.
- Financial execution remains a major risk: Boeing has recorded $20.5 billion in losses across five fixed-price development programs, making contract terms and cost control critical to the value of the new awards.
Boeing Expands Its Position in Next-Generation Fighters
Boeing has strengthened its position in the U.S. military aircraft market after securing the Navy’s next-generation F/A-XX fighter program, adding to its earlier victory in the Air Force’s F-47 competition.
The Navy contract, worth more than $20 billion during its initial development phase, puts Boeing ahead of Lockheed Martin and Northrop Grumman in another major Pentagon competition. Combined with the F-47 award, the victories give Boeing’s defense, space and security division an opportunity to establish a significant position in the next generation of U.S. tactical aircraft.
The programs could eventually create a much larger production opportunity, with the lifetime value of both aircraft potentially reaching hundreds of billions of dollars.
Digital Design Becomes a Competitive Advantage
The Pentagon required competing companies to use common design standards intended to make future upgrades and modifications easier. The objective is to allow aircraft to adapt more rapidly as technology changes and new military requirements emerge.
According to people familiar with the competitions, Boeing distinguished itself through its approach to these requirements and its use of digital design tools. These systems allow engineers, military officials and maintainers to test modifications and refine aircraft during development.
The strategy reflects a broader shift toward aircraft architectures designed for more flexible upgrades rather than platforms that remain largely unchanged throughout their service lives.
Years of Investment Behind the Wins
Boeing’s latest victories follow years of investment in fighter engineering and production capabilities. After losing the F-35 competition to Lockheed Martin in 2001, the company continued developing expertise through classified projects and upgrades for aircraft including the F-15 and F/A-18.
The F-15EX program subsequently helped demonstrate the value of that retained engineering capability, with the Air Force returning to purchases of the aircraft after previously ending procurement.
Following the pandemic, Boeing invested billions of dollars in production facilities, engineering capabilities and digital tools as it positioned itself for the next generation of fighter programs.
Contract Structure Remains a Critical Risk
Winning the programs does not automatically translate into financial success. Boeing has lost $20.5 billion across five fixed-price development programs, including the KC-46 tanker, T-7 trainer, MQ-25 refueling drone, Air Force One replacement and Starliner programs.
The experience has made contract structure particularly important. CEO Kelly Ortberg has said Boeing does not intend to pursue similar fixed-price development arrangements in the future as the company attempts to avoid repeating costly overruns.
The terms of the F-47 and F/A-XX agreements have not been fully disclosed, leaving investors with limited visibility into the eventual economics of the programs.
Two Fighters Could Create a Long-Term Defense Platform
The F-47 is expected to fly in 2028 and enter service in 2029, with the Air Force planning to purchase at least 185 aircraft to replace the F-22. The F/A-XX is expected to enter Navy service during the 2030s and ultimately replace the F/A-18 fleet.
Although the aircraft have important differences, both programs are intended to support air superiority alongside autonomous drones in a potential conflict involving China, according to defense analyst Roman Schweizer.
Boeing argues that developing the two aircraft simultaneously could reduce risk by allowing the company to share technologies and design features between the programs.
What Investors Should Watch Next
Boeing’s fighter victories materially expand the potential long-term opportunity for its defense business, but the financial outcome will depend on execution. The company must convert large development awards into sustainable programs without repeating the cost overruns that have affected previous fixed-price contracts.
The next milestones will include the evolution of contract terms, development schedules, aircraft testing and eventual production volumes. If Boeing can maintain control over costs while delivering the required capabilities, the fighter programs could become an important long-term contributor to its defense portfolio.
Comparison, examination, and analysis between investment houses
Leave your details, and an expert from our team will get back to you as soon as possible
* This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.
To read more about the full disclaimer, click here- Ronny Mor
- •
- 6 Min Read
- •
- ago 1 day
SKN | Could Samsung’s Record Profit Signal Another Major Phase of the AI Chip Boom?
Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is
- ago 1 day
- •
- 6 Min Read
Samsung Electronics is projecting its strongest quarterly profitability on record, underscoring the extraordinary impact that the artificial intelligence boom is
- Ronny Mor
- •
- 7 Min Read
- •
- ago 3 days
SKN | Could Summit’s Ivonescimab Help AstraZeneca Build the Next Generation of Cancer Treatments?
Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the
- ago 3 days
- •
- 7 Min Read
Summit Deal Puts Ivonescimab at the Center of AstraZeneca’s Strategy AstraZeneca is positioning its investment in Summit Therapeutics around the
- Lior mor
- •
- 7 Min Read
- •
- ago 6 days
SKN | Paramount and Warner Bros Discovery Merger to Create Skydance Entertainment Giant
The planned merger between Paramount Skydance and Warner Bros Discovery is moving closer to creating one of the largest
- ago 6 days
- •
- 7 Min Read
The planned merger between Paramount Skydance and Warner Bros Discovery is moving closer to creating one of the largest
- Ronny Mor
- •
- 7 Min Read
- •
- ago 6 days
SKN | Ford Defends U.S. Sales Ranking as Hyundai Narrows Gap in Competitive Auto Market
Ford Holds Third Place as Hyundai Closes the Sales Gap Ford Motor retained its No. 3 position in the U.S.
- ago 6 days
- •
- 7 Min Read
Ford Holds Third Place as Hyundai Closes the Sales Gap Ford Motor retained its No. 3 position in the U.S.